CRO’s revamped site provides a portal to dynamic content encouraging visitors to interact, contribute and learn about improving the efficiency of clinical trials
(Durham, NC: June 23, 2009) Health Decisions (www.healthdec.com, DIA Booth 1447), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces the launch of its new website at www.healthdec.com. The website is designed to let visitors engage in conversations about improving clinical trial efficiency while experiencing the company’s Agile Clinical Development platform. These connections are made through interactive tools and dynamic content, including a blog, audio and video content, articles, and white papers featuring a variety of viewpoints on ways to increase efficiency both from the Health Decisions team and third-party experts. Visitors are encouraged to join the conversation by submitting comments, asking questions on the FAQs page, and contacting the company with suggestions.
"We are excited to use this forum to share and discuss the concept of Agile Clinical Development. These principles have always defined how we work, and it is important to give our sponsors and other members of the drug development community an opportunity to weigh in," said Ryan Hedspeth, director of marketing for Health Decisions. "We hope this website will grow into a valuable resource for information on industry trends and for learning about the latest clinical trial processes and technologies."
The website also lets visitors easily access important background information on the company’s history, leadership team, services and therapeutic expertise, and includes information for job seekers, investigators, and media. Head to www.healthdec.com to see the new site, or click on one of the links below to go directly to a video or blog post that interests you.
Videos Subscribe
Site Management - Health Decisions"Site Management" - Mike Ford, director of data management, discusses ways to improve the performance of investigator sites.
Transparency and Control - Health Decisions"Transparency and Control" - CEO Michael Rosenberg discusses how providing the right information to the right eyes at the right time helps sponsors take control of their trials and make better decisions.
From the Blog Subscribe
"Web EDC is still coming up short for sponsors" - Lori Hill, manager of IT internal development points out the industry’s frustrations with current Web EDC systems, and suggests ways to move toward improvement.
See Us at DIA, Booth 1447
Stop by the Health Decisions exhibit, where the company will be demoing its SmartPen advanced EDC tool and asking attendees the question, “Are You Agile?” View the show press release.
Also, make sure to follow @healthdecisions on Twitter at for early access to breaking news from DIA and information on how to get in touch with adaptive research experts on the show floor.
About Health Decisions
Health Decisions (www.healthdec.com), a global clinical research organization (CRO), leads the industry in trial efficiency. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10 - 40% faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at www.healthdec.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Looking Forward in the Feasibility/AI Space
May 6th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Rohit Nambisan, CEO & founder of Lokavant looks into the future of feasibility studies, the integration of AI, and how they are driving more personalized approaches.